Dengue: Challenges for policy makers and vaccine developers
10.1007/s11908-014-0404-2
Saved in:
Main Authors: | Wilder-Smith, A, Macary, P |
---|---|
Other Authors: | MICROBIOLOGY AND IMMUNOLOGY |
Format: | Article |
Published: |
2020
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/181527 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Update on Dengue: Epidemiology, Virus Evolution, Antiviral Drugs, and Vaccine Development
by: Wilder-Smith, A., et al.
Published: (2011) -
Age specific differences in efficacy and safety for the CYD-tetravalent dengue vaccine
by: Wilder-Smith, Annelies, et al.
Published: (2016) -
CHARACTERIZATION OF DENGUE NEUTRALIZING ANTIBODIES USING RECOMBINANT ANTIBODIES TECHNOLOGY
by: XU MEIHUI
Published: (2015) -
Moving forward with Takeda's live chimeric tetravalent dengue vaccine
by: Wilder-Smith, Annelies
Published: (2017) -
Dengue vaccines for travelers
by: Wilder-Smith, A., et al.
Published: (2011)